APA

van der Burg M. E. L., Onstenk W., Boere I. A., Look M., Ottevanger P. B., de Gooyer D., Kerkhofs L. G. M., Valster F. A. A., Ruit J. B., van Reisen A. G. P. M., Goey S. H., van der Torren A. M. E., ten Bokkel Huinink D., Kok T. C., Verweij J. & van Doorn H. C. (20141215). Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. : European journal of cancer (Oxford, England : 1990).

Chicago

van der Burg M E L, Onstenk W, Boere I A, Look M, Ottevanger P B, de Gooyer D, Kerkhofs L G M, Valster F A A, Ruit J B, van Reisen A G P M, Goey S H, van der Torren A M E, ten Bokkel Huinink D, Kok T C, Verweij J and van Doorn H C. 20141215. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. : European journal of cancer (Oxford, England : 1990).

Harvard

van der Burg M. E. L., Onstenk W., Boere I. A., Look M., Ottevanger P. B., de Gooyer D., Kerkhofs L. G. M., Valster F. A. A., Ruit J. B., van Reisen A. G. P. M., Goey S. H., van der Torren A. M. E., ten Bokkel Huinink D., Kok T. C., Verweij J. and van Doorn H. C. (20141215). Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. : European journal of cancer (Oxford, England : 1990).

MLA

van der Burg M E L, Onstenk W, Boere I A, Look M, Ottevanger P B, de Gooyer D, Kerkhofs L G M, Valster F A A, Ruit J B, van Reisen A G P M, Goey S H, van der Torren A M E, ten Bokkel Huinink D, Kok T C, Verweij J and van Doorn H C. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. : European journal of cancer (Oxford, England : 1990). 20141215.